Basic information
Biomarker: Prostate-specific membrane antigen
Biomarker subtype: mRNA
Clinical application: prognosis(unfavorable)
Histology type: endometrioid endometrial carcinoma
Cohort characteristics
Country: USA
Region: NY
Followed up time : 17 (0-90)
Cohort age: 66;30-87
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
130 | EAC | 130 |
Sample information
Sample type : tissue
Clinical method: RT-PCR
Expression pattern : loss expression
Validation in cell line : urologic and gynecologic cell lines
Validation in cell method : RT-PCR,Methylation-Specific PCR,
Disease information
Statictics: Mean ;Range
Cohort age: 66;30-87
Related information
Description: Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma.
Approved symbol: FOLH1
Approved name: folate hydrolase 1
Locus type: gene with protein product
HGNC ID: HGNC:3788
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3788
Symbol status: Approved
Previous symbols: folate hydrolase (prostate-specific membrane antigen) 1
Alias symbols: FOLH
OMIM: 600934
Omim link: https://www.omim.org/entry/600934
NCBI name: 2346
NCBI link: https://www.ncbi.nlm.nih.gov/gene/2346
Summary: This gene encodes a type II transmembrane glycoprotein belonging to the M28 peptidase family. The protein acts as a glutamate carboxypeptidase on different alternative substrates, including the nutrient folate and the neuropeptide N-acetyl-l-aspartyl-l-glutamate and is expressed in a number of tissues such as prostate, central and peripheral nervous system and kidney. A mutation in this gene may be associated with impaired intestinal absorption of dietary folates, resulting in low blood folate levels and consequent hyperhomocysteinemia. Expression of this protein in the brain may be involved in a number of pathological conditions associated with glutamate excitotoxicity. In the prostate the protein is up-regulated in cancerous cells and is used as an effective diagnostic and prognostic indicator of prostate cancer. This gene likely arose from a duplication event of a nearby chromosomal region. Alternative splicing gives rise to multiple transcript variants encoding several different isoforms. [provided by RefSeq, Jul 2010]
Expression: Biased expression in duodenum (RPKM 94.9), prostate (RPKM 43.3) and 6 other tissues
NCBI gene expression https://www.ncbi.nlm.nih.gov/gene/2346#gene-expression
PDB ID: Q04609
PDB link: https://www.ebi.ac.uk/pdbe/entry/search/index/?searchParams=%7B%22q_uniprot%22:%5B%7B%22value%22:%22(Q04609)%22,%22condition1%22:%22AND%22,%22condition2%22:%22Contains%22%7D%5D,%22resultState%22:%7B%22tabIndex%22:0,%22paginationIndex%22:1,%22perPage%22:%2210%22,%22sortBy%22:%22Sort%20by%22%7D%7D
MF term ID: GO:1904492|GO:1904493
MF term name: Ac-Asp-Glu binding | tetrahydrofolyl-poly(glutamate) polymer binding
Source description: KEGG | TF
Term ID: KEGG:04977 | TF:M06350
Term name: Vitamin digestion and absorption | Factor: ZNF449; motif: NTGGGCGTAGGA